ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,728.80
0.41%
Dow Jones
42,052.19
0.69%
US Dollar vs MXN
20.2827
0.00%
Brent Oil
72.905
0.00%
Bitcoin
69,553.49
0.10%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX

  6. Perspective Therapeutics Inc (CATX) Cotización

Perspective Therapeutics Inc

Perspective Therapeutics Inc (CATX)

AMEX
12.09
0.28
(2.37%)
Cerrado 02 Noviembre 2:00PM
Delayed by 15 minutes
12.17
0.08
(0.66%)
Fuera de horario: 5:59PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
12.09
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
482,202
11.64 Rango del Día 12.21
2.201 Rango de 52 semanas 19.05
Capitalización de Mercado [m]
815.229M
Precio Anterior
11.81
Precio de Apertura
11.97
Hora
63100
@
12.09
Última hora de negociación
Volumen financiero
US$ 5,723,211
Precio Promedio Ponderado
11.8689
Volumen promedio (3 m)
830,095
Acciones en circulación
67,430,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-17.62
Beneficio por acción (BPA)
-0.69
turnover
1.43M
Beneficio neto
-46.51M

Acerca de Perspective Therapeutics Inc

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company¿s melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Mostrar más

Sector
Eating Places
Industria
Surgical,med Instr,apparatus
Sitio web
perspectivetherapeutics.com
Sede
Wilmington, Delaware, USA
Fundado
1983
Perspective Therapeutics Inc is listed in the Eating Places sector of the American Stock Exchange with ticker CATX. The last closing price for Perspective Therapeutics was US$11.81. Over the last year, Perspective Therapeutics shares have traded in a share price range of US$ 2.201 to US$ 19.05.

Perspective Therapeutics currently has 67,430,000 shares in issue. The market capitalisation of Perspective Therapeutics is US$796.35 million. Perspective Therapeutics has a price to earnings ratio (PE ratio) of -17.62.

CATX Últimas noticias

Más noticias

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results

SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

31 Octubre 2024
GlobeNewswire Inc.

Perspective Therapeutics to Participate in Upcoming Investor Conferences in November

SEATTLE, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

29 Octubre 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

24 Octubre 2024
Edgar (US Regulatory)

Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine

SEATTLE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

23 Octubre 2024
GlobeNewswire Inc.

Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey

SEATTLE, Oct. 16, 2024 (GLOBE NEWSWIRE) --  Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

16 Octubre 2024
GlobeNewswire Inc.

Form 8-K - Current report

11 Octubre 2024
Edgar (US Regulatory)

Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma Research

[212Pb]VMT01 was observed to be safe, and no dose-limiting toxicities were observed at the two doses tested (3.0 and 5.0 mCi)Prolonged progression-free survival and tumor response were observed in...

11 Octubre 2024
GlobeNewswire Inc.

Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma Research

SEATTLE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

10 Octubre 2024
GlobeNewswire Inc.

Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma Day

SEATTLE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

07 Octubre 2024
GlobeNewswire Inc.

Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear Medicine

SEATTLE, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...

30 Septiembre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.161.3411567476911.9312.4611.450851711.76049071CS
4-1.33-9.9105812220613.4213.569.6676614512.4706728CS
12-0.02-0.16515276630912.1116.559.6683009513.48535496CS
26-4.71-28.035714285716.819.058.16223685814.26677163CS
529.5366.7953667952.5919.052.201244945712.55247556CS
1568.327221.2862078133.76319.052.05172754711.25058356CS
2608.327221.2862078133.76319.052.05172754711.25058356CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TOVXTheriva Biologics Inc
US$ 1.9506
(33.60%)
82.95M
GSATGlobalstar Inc
US$ 1.3917
(32.54%)
200.15M
IBOImpact Biomedical Inc
US$ 2.68
(19.11%)
82.3k
CLDICalidi Biotherapeutics Inc
US$ 1.349
(14.33%)
2.86M
NCLNorthann Corp
US$ 0.2206
(13.71%)
1.42M
AUMNGolden Minerals Co
US$ 0.3201
(-13.44%)
188.7k
EFSH1847 Holdings LLC
US$ 0.4633
(-12.58%)
8.94M
PLAGPlanet Green Holdings Corp
US$ 2.02
(-12.17%)
20.07k
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 67.41
(-12.10%)
7.25M
SOARVolato Group Inc
US$ 0.2122
(-11.73%)
278.73k
GSATGlobalstar Inc
US$ 1.3917
(32.54%)
203.15M
TOVXTheriva Biologics Inc
US$ 1.9506
(33.60%)
85.55M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 30.83
(2.46%)
80.73M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.82
(-1.02%)
64.86M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 22.43
(-2.82%)
46.8M

CATX Discussion

Ver más
Tiger Money Tiger Money 3 meses hace
Thank you for sharing. I like the $10 call and for sure under $12
👍️0
Juschilln Juschilln 3 meses hace
Not claiming to be an expert by any means, but I'm looking at under $12, hopefully closer to around $10. May not get there, but that's me.
👍️0
Tiger Money Tiger Money 3 meses hace
Any entry point suggestions? Pretty much flying blind here
👍️0
Juschilln Juschilln 3 meses hace
Kinda what I'm thinking . . .
👍️0
Tiger Money Tiger Money 3 meses hace
Time to get in again?
👍️0
Monksdream Monksdream 5 meses hace
CATX 1for10 Monday 6/17
👍️0
Juschilln Juschilln 5 meses hace
Dang!
👍️0
CenterLong CenterLong 5 meses hace
$CATX A One for Ten reverse split was authorized at shareholders meeting. Oh well, to bad.
👍️0
Juschilln Juschilln 6 meses hace
We should do well here; barring any reverse split. That would suck.
👍️0
splintered sunlight splintered sunlight 6 meses hace
https://za.investing.com/news/rbc-capital-bulish-on-perspective-therapeutics-stock-cites-trt-sector-93CH-3146238
👍️0
CenterLong CenterLong 6 meses hace
Got Out at $1.58 sold a majority of my positions in $CATX I Was going to hold but the pending 1 for 10 reverse split is too risky, Kept a several thousand share grub stake. Made Money and feel good. Hmmm wondering whomever purchased my shares at $1.58 will soon have a cost basis of $15.80........and one tenth the amount of shares....it just never goes good with reverse splits on micro cap companies. A long road of averaging down if your lucky.....Glad I'm out.
👍️0
CenterLong CenterLong 6 meses hace
$CATX was looking really good with a steady appreciation all thru Jan. Feb. Mar. A good candidate for momentum buyers? Now after all the dilution they are asking shareholders to authorize a Reverse split 1 Share for 10 Shares. 1 for 10........YIKES
👍️0
CenterLong CenterLong 6 meses hace
I Don't know, Almost got out of $CATX when they said they were going to sell 200million shares but I put the blinders on and they started selling shares like crazy. The price went from .28 to 1.60 or a 450PERCENT gain!! so much for the dilution theory!!
👍️0
Juschilln Juschilln 7 meses hace
I'm seeing a hefty merger or an all out buy out by one of the "big boys". Just hoping.
👍️0
CenterLong CenterLong 7 meses hace
Same here, holding about 5 years, took some profit at 400% up. Been thinking maybe the $5 range. It will take some Brass Balls to hold out for $20. What do you see that says $20?
👍️0
CenterLong CenterLong 7 meses hace
$CATX Just about a Dozen New Yearly Highs in the last 2 or 3 months. 500% (thereabouts) up from it's low.
👍️0
Monksdream Monksdream 7 meses hace
CATX new 52=hi
👍️0
Juschilln Juschilln 7 meses hace
Been holding and adding for over 4 yrs, so glad to see it's potential finally recognized. Long time waiting for all us, feels good. Plan on riding this into the $20s!!! LOL!
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
CATX MASSIVE BREAK OUT
👍️0
splintered sunlight splintered sunlight 7 meses hace
Love it - THANKS!!!!!!
👍️0
CenterLong CenterLong 7 meses hace
Oppenheimer Raises Target Again. Oppenheimer raises target for the third time from 1.2 to $1.50 YES what a run "HousesMoney"
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
CATX 1.50 TARGET COMING IN
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
CATX...BREAKING OUT
👍️0
CenterLong CenterLong 7 meses hace
Your Prediction was correct $CATX closed up 320 PERCENT after your post. Looking for another Plus 100 PERCENT from here.
👍️0
Monksdream Monksdream 7 meses hace
CATX under $2
👍️0
TrendTrade2016 TrendTrade2016 7 meses hace
CATX..BREAK OUT PLAY TO 1.50 UNDERWAY!!
👍️0
TrendTrade2016 TrendTrade2016 8 meses hace
CATX////LONG HERE...SLOW AND STEADY PLAY...WATCH THE MAGIC
👍️0
TrendTrade2016 TrendTrade2016 8 meses hace
CATX...BACK IN HERE ON THIS BREAK OUT!!
👍️0
CenterLong CenterLong 8 meses hace
WoW $CATX hits another new high $1.17 wonder how high it will go on this run?
👍️0
splintered sunlight splintered sunlight 8 meses hace
Hopefully yes!!!!!!
👍️0
CenterLong CenterLong 8 meses hace
Nice run up $CATX from .2 to over $1.00 Oppenheimer's target of $1.20 may have to be increased.
👍️ 1
ErnieBilco ErnieBilco 9 meses hace
And the border is secure. Don't believe a thing the SEC or any other gooberment entity tells you...

THEY ARE LIARS AND CHEATS.
👍️0
Agoura Guy Agoura Guy 9 meses hace
I HAVE BEEN TRADING 0DTE OPTIONS SINCE JUNE..... UNLIKE YOU WHO GRIFTS GULLIBLE SUCKERS OUT OF THEIR HARD EARNED MONEY!!!!
👍️ 1 🚫 1
TrendTrade2016 TrendTrade2016 9 meses hace
HIDE UNDER A ROCK...YOU COMPLETLY MAHE A FOOL OF YOURSELF IN THE LAST YEAR
👍️0
Agoura Guy Agoura Guy 9 meses hace
I AM LOADING UP ON MARCH 15 SPY $500 PUTS!!!!!!!!!!


👍️ 1 〽️ 1
TrendTrade2016 TrendTrade2016 9 meses hace
WHAT HAPPENED TO THE MARKET CRASH THIS WEEK...BIG RUG PULL YOU KEEP SPEAKING OF, YOU HAVE NO CLUE WHAT YOU ARE DOING
👍️0
Agoura Guy Agoura Guy 9 meses hace
THE SEC IS TRACKING PUMP AND DUMP CON ARTISTS!!!!!!!!!

👍️ 1 🚫 1
TrendTrade2016 TrendTrade2016 9 meses hace
BEWARE OF THE WORST TRADEVIN THE MARKET AND THE WORST MARKET CALL IVE HAVE EVER SEEN
👍️0
TrendTrade2016 TrendTrade2016 9 meses hace
CATX WHAT A BEAST
👍️0
CenterLong CenterLong 9 meses hace
$CATX IS UP 100 PERCENT since the man started the"pump" Guess we must have known something. CU-CHING
👍️ 1
Sctrben Sctrben 9 meses hace
Thanks for the heads up, fortunately for him he may have jumped into a holding here that’s going to meet his bragging/promoting needs when it gets bought out
👍️0
TrendTrade2016 TrendTrade2016 9 meses hace
LAMO watch the master
👍️0
Agoura Guy Agoura Guy 9 meses hace
BEWARE OF THE CRIMINAL STOCK PROMOTER FROM NOVA SCOTIA, CANADA. THE SEC IS AFTER HIM FOR MULTIPLE SECURITIES VIOLATIONS!!!!!!!

CATX IS JUST ONE OF MANY PUMP AND DUMPS THIS MAGGOT FRONT RUNS AND DUMPS ON SUCKERS!!!!!

👍️ 1 🚫 1
CenterLong CenterLong 9 meses hace
Insiders Buying $CATX More new Year Highs coming up
👍️ 1
CenterLong CenterLong 9 meses hace
WAHOOOOO, $CATX CRANKING !!!!YEAH!!!!
👍️ 1
TrendTrade2016 TrendTrade2016 9 meses hace
CATX massive break out
👍️ 1
TrendTrade2016 TrendTrade2016 10 meses hace
CATX...MINI MONSTER BUILDING ITS FOUNDATION
👍️0
TrendTrade2016 TrendTrade2016 10 meses hace
CATX BREAK OUT
👍️0
TrendTrade2016 TrendTrade2016 10 meses hace
CATX mini monster ready to beast
👍️0
TrendTrade2016 TrendTrade2016 10 meses hace
CATX...BIO BEAST
👍️0

Su Consulta Reciente

AMEX
CATX
Perspective Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados